Itron (NASDAQ:ITRI) CFO Sells $28,258.00 in Stock

Itron, Inc. (NASDAQ:ITRI) CFO Joan Hooper sold 355 shares of the firm’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total transaction of $28,258.00. Following the completion of the sale, the chief financial officer directly owned 117,920 shares in the company, valued at approximately $9,386,432. This trade represents a 0.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Trading Up 1.1%

Shares of Itron stock traded up $0.93 during trading on Thursday, reaching $82.28. 376,875 shares of the stock were exchanged, compared to its average volume of 937,478. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97. The stock’s fifty day moving average is $88.85 and its 200 day moving average is $94.73. The firm has a market cap of $3.65 billion, a price-to-earnings ratio of 13.15, a price-to-earnings-growth ratio of 0.68 and a beta of 1.35. Itron, Inc. has a 1 year low of $77.77 and a 1 year high of $142.00.

Itron (NASDAQ:ITRI) last posted its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.23. The company had revenue of $586.98 million during the quarter, compared to analyst estimates of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. Itron’s revenue for the quarter was down 3.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, equities research analysts expect that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.

Institutional Trading of Itron

A number of hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in shares of Itron by 2.3% in the 3rd quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company’s stock worth $731,809,000 after purchasing an additional 132,329 shares in the last quarter. Impax Asset Management Group plc boosted its position in shares of Itron by 127.3% in the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock worth $197,153,000 after purchasing an additional 890,040 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Itron by 20.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company’s stock worth $137,659,000 after purchasing an additional 265,039 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Itron by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock worth $106,340,000 after purchasing an additional 6,598 shares in the last quarter. Finally, Handelsbanken Fonder AB boosted its position in shares of Itron by 6.0% in the 3rd quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company’s stock worth $124,545,000 after purchasing an additional 56,318 shares in the last quarter. 96.19% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ITRI has been the subject of a number of analyst reports. Needham & Company LLC initiated coverage on shares of Itron in a report on Friday, March 6th. They set a “buy” rating and a $124.00 target price for the company. Zacks Research upgraded shares of Itron from a “strong sell” rating to a “hold” rating in a report on Thursday, February 26th. Guggenheim set a $155.00 price objective on shares of Itron in a report on Friday, February 13th. TD Cowen decreased their target price on Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Finally, Oppenheimer increased their target price on Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research report on Thursday, April 16th. Eight analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $131.22.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.